Doctor Checking a Form

PREVIOUS CLINICAL TRIALS 

Enrollment may be closed for some of these trials. Please contact the site for more information. 

OBSTRUCTIVE SLEEP APNEA

Obstructive Sleep Apnea (OSA) is the most common and serious sleep disorder that affects approximately 20 million people in the United States. The purpose of this study is to evaluate the safety and efficacy of an investigational medication in participants with obstructive sleep apnea.

 
OSA_edited.jpg

STUDY: EVALUATE THE EFFECTIVENESS AND SAFETY OF INVESTIGATIONAL DRUGS IN PARTICIPANTS WITH OBSTRUCTIVE SLEEP APNEA

At Santa Monica Clinical Trials, we are actively recruiting qualified participants for a study evaluating the effectiveness and safety of a study treatment for obstructive sleep apnea. If you are interested and available, and you meet the qualifications outlined below, please contact us today.

  • Length of trial: up to 10 weeks 

  • Age range: 18-65 years of age for men, 18-75 years of age for women

  • Treatment: The effectiveness and safety of oral investigational drugs in treating obstructive sleep apnea. 

All of our clinical trials are performed at no cost to you. No medical insurance is necessary and you may be compensated for your participation.

EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITH PRADER-WILLI SYNDROME

Prader-Willi Syndrome (PWS) is a rare complex genetic disorder characterized by a myriad of symptoms including short stature, hypotonia, hyperphagia, early onset childhood obesity, excessive daytime sleepiness, and cognitive dysfunction. The purpose of this study is to evaluate the safety and efficacy of the study drug compared with a  placebo in treating excessive daytime sleepiness in patients with Prader-Willi Syndrome.

 
Mother and Son

STUDY: EVALUATE THE EFFECTIVENESS AND SAFETY OF AN INVESTIGATIONAL DRUG COMPARED TO A PLACEBO IN TREATING EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITH PRADER-WILLI SYNDROME

At Santa Monica Clinical Trials, we are actively recruiting qualified participants for a study evaluating the effectiveness and safety of a study treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome.  If you are interested and available, and you meet the qualifications outlined below, please contact us today.

  • Length of trial: up to 1 year

  • Age range: 6 - 65 years of age

  • Treatment: The effectiveness and safety of an oral investigational drug compared to a placebo in treating excessive daytime sleepiness in patients with Prader-Willi Syndrome.

All of our clinical trials are performed at no cost to you. No medical insurance is necessary and you may be compensated for your participation.

ATOPIC DERMATITIS / ECZEMA

Atopic Dermatitis is a common skin condition that is also called eczema. Itching, also called pruritus, is a common symptom of atopic dermatitis that can cause a person to scratch, which in turn can lead to red, thick, dry, cracked, inflamed, flaky, or bleeding skin. Many people with atopic dermatitis find that medicines such as creams, steroids, or antihistamines do not relieve the symptoms associated with atopic dermatitis. The purpose of this study is to evaluate the efficacy of an investigational drug on symptoms associated with atopic dermatitis and to assess the safety of the investigational drug.

 
Skin-itching-and-scratching-Dermatologis

STUDY: EVALUATE THE EFFICACY OF A NEW TREATMENT FOR ATOPIC DERMATITIS

​At Santa Monica Clinical Trials, we are actively recruiting qualified participants for a study evaluating the efficacy and safety of a new treatment for atopic dermatitis. If you are interested and available, and you meet the qualifications outlined below, please contact us today.

  • Length of trial: Approximately 12 weeks

  • Age range: Healthy adults 18-70 years of age

  • Treatment: The efficacy and safety of an oral investigational drug

All of our clinical trials are free of cost. No medical insurance is necessary and you may be compensated for your participation.

SMITH-MAGENIS SYNDROME

Smith-Magenis Syndrome (SMS) is a rare genetic disorder that disrupts individuals sleep patterns and causes patients to sleep during the day and wake at night. SMS is also known to cause aggression in patients. The purpose of this research study is to investigate a potential treatment to address sleep disturbances in Smith-Magenis Syndrome (SMS) patients.

 
Image by Aaron Burden

STUDY: EVALUATE THE EFFICACY OF TASIMELTEON IN IMPROVING NIGHTTIME SLEEP IN PATIENTS WITH SMS

​At Santa Monica Clinical Trials, we are actively recruiting qualified participants for a study evaluating the efficacy of Tasimelteon in improving nighttime sleep in patients with SMS.

  • Age range:  Males or females between 3-65 years of age

  • Treatment: The efficacy and safety of Tasimelteon. 

All of our clinical trials are free of cost. No medical insurance is necessary and you may be compensated for your participation.

UPCOMING CLINICAL TRIALS


If you’re interested in participating in one of our upcoming studies, please contact our office today to inquire about your candidacy. Our research team at Santa Monica Clinical Trials regularly accepts new and exciting studies and is more than happy to discuss the details further with you.